<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37352207</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>COVID-19 symptom load as a risk factor for chronic pain: A national cross-sectional study.</ArticleTitle><Pagination><StartPage>e0287554</StartPage><MedlinePgn>e0287554</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0287554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0287554</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Emerging evidence suggests that a COVID-19 infection with a high initial severity may be associated with development of long-COVID conditions such as chronic pain. At the population level, it is unknown if severity of a COVID-19 infection might be a new risk factor for chronic pain above and beyond the traditional slate of pre-established risk factors. The purpose of this study is to examine whether COVID-19 severity of infection may be a new risk factor for chronic pain.</AbstractText><AbstractText Label="METHODS">Using data from the 2021 National Health Interview Survey (n = 15,335), this study examined the adjusted odds of experiencing high frequency levels of pain in the past 3 months for those who reported no/mild symptoms from a COVID-19 infection, and those reporting moderate/severe symptoms from COVID-19, compared to those never infected. A 1:1:1 propensity score matched analysis was also performed to examine the odds of pain.</AbstractText><AbstractText Label="RESULTS">Prevalence of pain was higher in the moderate/severe symptom group compared to the no infection group (25.48% vs 19.44%, p &lt;0.001). Both the adjusted model (odds ratio [OR] = 1.28, 95% confidence interval [CI] = 1.09, 1.51) and matched model (OR = 1.45, CI = 1.14, 1.83) revealed higher odds of pain for those with moderate/high COVID-19 symptoms compared to no infection.</AbstractText><AbstractText Label="CONCLUSIONS">A moderate/highly symptomatic COVID-19 infection may be a new risk factor for chronic pain. As the absolute number of severe COVID-19 infections continues to rise, overall prevalence of chronic pain may also increase. While knowledge continues to unfold on long-haul symptoms, prevention of severe infections remains essential.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Romeiser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romeiser</LastName><ForeName>Jamie L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-0281-8933</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Upstate Medical University, Syracuse, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morley</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Upstate Medical University, Syracuse, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sunitha M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-9418-9849</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Surgical Services, Stony Brook University Medical Center, Stony Brook, New York, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Stony Brook University Medical Center, Stony Brook, New York, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059350" MajorTopicYN="Y">Chronic Pain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37352207</ArticleId><ArticleId IdType="pmc">PMC10289324</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0287554</ArticleId><ArticleId IdType="pii">PONE-D-23-09591</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2023 [Cited March 9, 2023]. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions 2022 [Cited October 14 2022]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/.</Citation></Reference><Reference><Citation>Center for Disease Control. Nearly One in Five American Adults Who Have Had COVID-19 Still Have &#x201c;Long COVID&#x201d; 2022 [Cited December 15 2022]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm.</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al.. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. Epub 2022/12/08. doi: 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. Epub 2021/05/27. doi: 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;63. Epub 2020/10/09. doi: 10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kume J, Jumbo A, Voltmer C, Luo F. Functional Limitations Associated with Frailty Risk in Older Adults Increased after COVID-19 Infection in 2020 CDC NHIS Data. J Geriatr Med Gerontol. 2022; 8(134).</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;64. Epub 2021/04/23. doi: 10.1038/s41586-021-03553-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala K, Martens J, Abd-Elsayed A. Post-COVID Pain Syndromes. Curr Pain Headache Rep. 2022;26(5):379&#x2013;83. Epub 2022/03/11. doi: 10.1007/s11916-022-01038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01038-6</ArticleId><ArticleId IdType="pmc">PMC8907389</ArticleId><ArticleId IdType="pubmed">35267156</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyth FM, Van Der Windt DA, Croft PR. Chronic Disabling Pain: A Significant Public Health Problem. Am J Prev Med. 2015;49(1):98&#x2013;101. Epub 2015/06/22. doi: 10.1016/j.amepre.2015.01.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2015.01.008</ArticleId><ArticleId IdType="pubmed">26094230</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770. Epub 2011/10/08. doi: 10.1186/1471-2458-11-770</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-770</ArticleId><ArticleId IdType="pmc">PMC3201926</ArticleId><ArticleId IdType="pubmed">21978149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022;163(2):e328&#x2013;e32. Epub 2021/05/15. doi: 10.1097/j.pain.0000000000002291 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002291</ArticleId><ArticleId IdType="pubmed">33990113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic Pain and High-impact Chronic Pain Among U.S. Adults, 2019. NCHS Data Brief. 2020;(390):1&#x2013;8. Epub 2020/11/06. .</Citation><ArticleIdList><ArticleId IdType="pubmed">33151145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, et al.. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults&#x2014;United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001&#x2013;6. Epub 2018/09/14. doi: 10.15585/mmwr.mm6736a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6736a2</ArticleId><ArticleId IdType="pmc">PMC6146950</ArticleId><ArticleId IdType="pubmed">30212442</ArticleId></ArticleIdList></Reference><Reference><Citation>Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al.. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003&#x2013;7. Epub 2015/04/07. doi: 10.1097/j.pain.0000000000000160</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000160</ArticleId><ArticleId IdType="pmc">PMC4450869</ArticleId><ArticleId IdType="pubmed">25844555</ArticleId></ArticleIdList></Reference><Reference><Citation>Axon DR, Le D. Predictors of pain severity among community-dwelling older adults with pain in the United States: Findings from a cross-sectional, retrospective study using 2017 Medical Expenditure Panel Survey. Medicine. 2021;100(20):e26011. Epub 2021/05/21. doi: 10.1097/MD.0000000000026011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000026011</ArticleId><ArticleId IdType="pmc">PMC8137030</ArticleId><ArticleId IdType="pubmed">34011100</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273&#x2013;e83. Epub 2019/05/14. doi: 10.1016/j.bja.2019.03.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.03.023</ArticleId><ArticleId IdType="pmc">PMC6676152</ArticleId><ArticleId IdType="pubmed">31079836</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. About the National Health Interview Survey 2022 [Cited October 12 2022]. https://www.cdc.gov/nchs/nhis/index.htm.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41&#x2013;55.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score. The American Statistician. 1985;39(1):33&#x2013;8. doi: 10.1080/00031305.1985.10479383</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00031305.1985.10479383</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399&#x2013;424. Epub 2011/08/06. doi: 10.1080/00273171.2011.568786</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW, Acharya KP. Propensity score matching for causal inference and reducing the confounding effects: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2:e18. doi: 10.54724/lc.2022.e18</Citation><ArticleIdList><ArticleId IdType="doi">10.54724/lc.2022.e18</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Yan X, Zhao F, Teng Y, Sun X, Lv Z, et al.. Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer. JAMA Network Open. 2022;5(11):e2239788&#x2013;e. doi: 10.1001/jamanetworkopen.2022.39788</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.39788</ArticleId><ArticleId IdType="pmc">PMC9631104</ArticleId><ArticleId IdType="pubmed">36322088</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Jembere N, Chiu M. Propensity score matching and complex surveys. Stat Methods Med Res. 2018;27(4):1240&#x2013;57. Epub 2016/07/28. doi: 10.1177/0962280216658920</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216658920</ArticleId><ArticleId IdType="pmc">PMC5843030</ArticleId><ArticleId IdType="pubmed">27460539</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr DB, Fox DM, Rothstein MA, Spellman CM. Pain Management and Public Health: Introduction to the Special Section. Am J Public Health. 2019;109(1):17&#x2013;8. Epub 2019/01/01. doi: 10.2105/AJPH.2018.304841</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2018.304841</ArticleId><ArticleId IdType="pmc">PMC6301426</ArticleId><ArticleId IdType="pubmed">32941764</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi V, Olulana O, Avula V, Chaudhary D, Khan A, Shahjouei S, et al.. Racial, Economic, and Health Inequality and COVID-19 Infection in the United States. J Racial Ethn Health Disparities. 2021;8(3):732&#x2013;42. Epub 2020/09/03. doi: 10.1007/s40615-020-00833-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-020-00833-4</ArticleId><ArticleId IdType="pmc">PMC7462354</ArticleId><ArticleId IdType="pubmed">32875535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al.. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66. Epub 2021/07/02. doi: 10.5888/pcd18.210123</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210123</ArticleId><ArticleId IdType="pmc">PMC8269743</ArticleId><ArticleId IdType="pubmed">34197283</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Global Health. 2021;6(12). Epub 2021/12/18. doi: 10.1136/bmjgh-2021-006434</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006434</ArticleId><ArticleId IdType="pmc">PMC8678541</ArticleId><ArticleId IdType="pubmed">34916273</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, et al.. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021;25(6):1342&#x2013;54. Epub 2021/02/24. doi: 10.1002/ejp.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Zis P, Ioannou C, Artemiadis A, Christodoulou K, Kalampokini S, Hadjigeorgiou GM. Prevalence and Determinants of Chronic Pain Post-COVID; Cross-Sectional Study. J Clin Med. 2022;11(19):5569. doi: 10.3390/jcm11195569</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195569</ArticleId><ArticleId IdType="pmc">PMC9573502</ArticleId><ArticleId IdType="pubmed">36233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, de-la-Llave-Rinc&#xf3;n AI, Ortega-Santiago R, Ambite-Quesada S, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al.. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2022;163(9):e989&#x2013;e96. Epub 2021/12/17. doi: 10.1097/j.pain.0000000000002564 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnie RJ, Schumacher MA, Clark JD, Kesselheim AS. Pain Management and Opioid Regulation: Continuing Public Health Challenges. Am J Public Health. 2019;109(1):31&#x2013;4. Epub 2019/01/01. doi: 10.2105/AJPH.2018.304881</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2018.304881</ArticleId><ArticleId IdType="pmc">PMC6301400</ArticleId><ArticleId IdType="pubmed">32941766</ArticleId></ArticleIdList></Reference><Reference><Citation>Haack M, Simpson N, Sethna N, Kaur S, Mullington J. Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications. Neuropsychopharmacology. 2020;45(1):205&#x2013;16. doi: 10.1038/s41386-019-0439-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-019-0439-z</ArticleId><ArticleId IdType="pmc">PMC6879497</ArticleId><ArticleId IdType="pubmed">31207606</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715&#x2013;24. Epub 2012/05/23. doi: 10.1016/j.jpain.2012.03.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.03.009</ArticleId><ArticleId IdType="pubmed">22607834</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahan AE, McKenna C, Miller GF, Guy GP. Prevalence of Nonpharmacologic and Pharmacologic Therapies Among Noncancer Chronic Pain&#x2013;Associated Ambulatory Care Visits, 2016. Am J Prev Med. 2020;59(4):e175&#x2013;e7. doi: 10.1016/j.amepre.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC9809977</ArticleId><ArticleId IdType="pubmed">32843280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentschel CB, Abramoff BA, Dillingham TR, Pezzin LE. Race, ethnicity, and utilization of outpatient rehabilitation for treatment of post COVID-19 condition. PM R. 2022;14(11):1315&#x2013;24. Epub 2022/07/06. doi: 10.1002/pmrj.12869</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12869</ArticleId><ArticleId IdType="pmc">PMC9350262</ArticleId><ArticleId IdType="pubmed">35789541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerns RD. Social and Behavioral Sciences: Response to the Opioid and Pain Crises in the United States. Am J Public Health. 2022;112(S1):S6&#x2013;s8. Epub 2022/02/11. doi: 10.2105/AJPH.2022.306773</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2022.306773</ArticleId><ArticleId IdType="pmc">PMC8842200</ArticleId><ArticleId IdType="pubmed">35143280</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeiser JL, Labriola J, Meliker JR. Geographic patterns of prescription opioids and opioid overdose deaths in New York State, 2013&#x2013;2015. Drug and Alcohol Dependence. 2019;195:94&#x2013;100. doi: 10.1016/j.drugalcdep.2018.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2018.11.027</ArticleId><ArticleId IdType="pubmed">30605866</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Prescription Opioid Overdose Death Maps 2022 [Cited December 15 2022]. https://www.cdc.gov/drugoverdose/deaths/prescription/maps.html.</Citation></Reference><Reference><Citation>Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al.. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924&#x2013;44. Epub 2022/02/25. doi: 10.1016/S0140-6736(22)00152-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sud A, Buchman DZ, Furlan AD, Selby P, Spithoff SM, Upshur REG. Chronic Pain and Opioid Prescribing: Three Ways for Navigating Complexity at the Clinical-Population Health Interface. Am J Public Health. 2022;112(S1):S56&#x2013;s65. Epub 2022/02/11. doi: 10.2105/ajph.2021.306500</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.2021.306500</ArticleId><ArticleId IdType="pmc">PMC8842204</ArticleId><ArticleId IdType="pubmed">35143271</ArticleId></ArticleIdList></Reference><Reference><Citation>Duca LM, Helmick CG, Barbour KE, Nahin RL, Von Korff M, Murphy LB, et al.. A Review of Potential National Chronic Pain Surveillance Systems in the United States. J Pain. 2022;23(9):1492&#x2013;509. Epub 2022/04/15. doi: 10.1016/j.jpain.2022.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2022.02.013</ArticleId><ArticleId IdType="pmc">PMC9464678</ArticleId><ArticleId IdType="pubmed">35421595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendricks B, Price BS, Dotson T, Kimble W, Davis S, Khodaverdi M, et al.. If You Build It, Will They Come? Is Test Site Availability a Root Cause of Geographic Disparities in COVID-19 Testing? Public Health. 2022. doi: 10.1016/j.puhe.2022.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.09.009</ArticleId><ArticleId IdType="pmc">PMC9485419</ArticleId><ArticleId IdType="pubmed">36764116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>